newsfilter
← Latest News
GlobeNewswire·

Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates

Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected mid-2026Rita Jain, M.D. appointed to Board of DirectorsCash and short-term investments of approximately $113